Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Vaccine|July 13, 2004
Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccineDarron R Brown, Kenneth H Fife, Cosette M Wheeler, et al.Plos One|June 25, 2015
Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive AspergillosisDionysios Neofytos, Radha Railkar, Kathleen M Mullane, et al.Nature Communications|January 9, 2016
Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccinationSlim Fourati, Razvan Cristescu, Andrey Loboda, et al.Journal of Translational Medicine|June 23, 2014
High-dimensional analysis of the aging immune system: verification of age-associated differences in immune signaling responses in healthy donorsDiane M Longo, Brent Louie, Jason Ptacek, et al.Clinical and Vaccine Immunology : CVI|April 13, 2007
Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccinesSuzanne M Garland, Marc Steben, Mauricio Hernandez-Avila, et al.Clinical Pharmacology and Therapeutics|December 24, 2019
Fine-Needle Aspiration for the Evaluation of Hepatic Pharmacokinetics of Vaniprevir: A Randomized Trial in Patients With Hepatitis C Virus InfectionWei Gao, Andrea L Webber, Jill Maxwell, et al.The New England Journal of Medicine|May 15, 2007
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseasesSuzanne M Garland, Mauricio Hernandez-Avila, Cosette M Wheeler, et al.The Lancet. Oncology|May 3, 2005
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trialLuisa L Villa, Ronaldo L R Costa, Carlos A Petta, et al.Vaccine|June 7, 2006
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18Luisa L Villa, Kevin A Ault, Anna R Giuliano, et al.Pageof 2